Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate…

Overview of attention for article published in Clinical Journal of The American Society of Nephrology, October 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,326 followers.

CKD stage 3未満のT2D患者に対してSGLT2阻害薬とGLP1RAはDPP4阻害薬やSU薬と比べて腎症及び全死亡を減少させる。 https://t.co/p5uus35YFZ

RT @KidneyInCVD: Kidney Outcomes with GLP-1RAs, SGLT2 Inhibitors, DPP-4... : Clinical Journal of the American Society of Nephrology https:/…

Kidney Outcomes with GLP-1RAs, SGLT2 Inhibitors, DPP-4... : Clinical Journal of the American Society of Nephrology https://t.co/QYbNUhGcAC

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.